secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ardent Health, Inc. (ARDT)
CIK:        0001756655
Form:       8-K
Filed at:   2026-03-04T23:59:59+00:00
Accession:  0001628280-26-014640
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ardent Health Q4 adj EBITDA down 26.6% to $134M; 2026 guidance issued
---------------------------------------------------------------------

- Q4 total revenue $1.605B (flat YoY); net income $45M vs $114M prior year.
- Q4 adjusted EBITDA $134M (down 26.6% YoY) due to annualization of prior-year benefits.
- Full-year 2025 revenue $6.32B (+6%); adjusted EBITDA $545M (+9.3%); margin +20bps to 8.6%.
- 2026 guidance: revenue $6.4B-$6.7B, adjusted EBITDA $485M-$535M, reflecting headwinds.
- Net leverage improved to 0.8x; operating cash flow $471M (+49% YoY); share buyback $3M in Q4.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1756655/000162828026014640/0001628280-26-014640-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1756655/000162828026014640/ardt-20260304.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-014640

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer